Article Details
Retrieved on: 2024-04-09 20:06:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
HAMILTON, ON and BOSTON , April 9, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here